Skip to main content
Pfizer Ventures investing $600M in biotechnology
6/8/2018

Pfizer Ventures, the venture investment group for Pfizer, is investing $600 million in biotechnology, with 25% dedicated to neuroscience. The company initially will focus on neurodegeneration, neuroinflammation and neurometabolic disorders.

Full Story: